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Abstract
IMPORTANCE Little is known about variation in outcomes of surgery or about the factors associated
with such variation.
OBJECTIVES To evaluate variation in patient outcomes and costs for primary hip and knee
replacement across health areas in England and to identify whether patient, surgical, or hospital
factors are associated with such variation.
DESIGN, SETTING, AND PARTICIPANTS This cohort study used data from the National Joint
Registry, linked to English Hospital Episode Statistics and Patient Reported OutcomeMeasures data
sets, for 383 382 adult patients who underwent primary total hip replacement (THR) or primary total
and unicompartmental knee replacement (TKR) surgical procedures from January 2014 to December
2016. Geographical Information Systems were used to display maps describing adjusted estimates
of variation in outcomes across health areas. Data analysis took place from January 2018 to
August 2019.
EXPOSURES Patient characteristics (eg, age, sex, bodymass index [BMI], and socioeconomic
deprivation), surgical factors (eg, surgeon volume and grade), and hospital organizational factors (eg,
number of operating theaters, number of specialist consultants, and hospital volume).
MAINOUTCOMES ANDMEASURES Length of stay (LOS), bed-day costs, change in Oxford hip or
knee scores 6months after surgery, and complications 6months after surgery.
RESULTS A total of 173 107 patients (mean [SD] age, 69.3 [10.7] years; mean [SD] BMI, 28.9 [5.2])
underwent primary THR and 210 275 patients (mean [SD] age 69.7 [9.4] years; mean [SD] BMI, 31.1
[5.5]) underwent primary TKR, nested in 207 health areas. A number of factors were associated with
longer LOS, higher bed-day costs, smaller changes in Oxford hip or knee scores, and a higher
percentage of complications, including a workforce with a higher number of less experienced
physicians (eg, LOS for less experienced surgeons, THR: regression coefficient, 0.02; 95% CI, 0.01 to
0.03; P < .001; TKR: regression coefficient, 0.01; 95% CI, 0.01 to 0.02; P < .001), public hospitals
(eg, bed-day costs for private hospitals, THR: regression coefficient, −0.15; 95% CI, −0.15 to −0.14;
P < .001; TKR: regression coefficient, −0.19; 95% CI, −0.19 to −0.19; P < .001), low volume of surgical
procedures per surgeon (eg, change in Oxford hip or knee scores for lead surgeonwith10 vs >150
surgical procedures per year, THR: regression coefficient, −1.03; 95% CI, −1.47 to −0.58; P < .001;
TKR: regression coefficient, −0.54; 95% CI, −1.01 to −0.06), and low volume of surgical procedures
per hospital (eg, percentage of complications for hospitals with200 vs500 surgical procedures
per year, THR: regression coefficient, 0.12; 95% CI, 0.04 to 0.21; P < .001; TKR: regression
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Abstract (continued)
coefficient, 0.09; 95% CI, 0.01 to 0.18; P = .03). Although these factors did not attenuate the
magnitude of variation across health areas, they had ecological correlations with the observed
geographical variations in outcomes of surgery by health area. For example, the percentage of public
and private hospitals was ecologically correlated at the health area level with longer and shorter
stays, respectively (public hospital, THR: ρ, 0.41; public hospital, TKR: ρ, 0.44; private hospital, THR:
ρ, −0.37; private hospital, THR: ρ, −0.38). Across health areas, estimatedmean length of stay ranged
from 3 to 7 days, and associated bed-day costs ranged from £4727 ($5827) to £8800 ($10 848) for
both total hip and knee replacement. The absolute estimatedmean change in Oxford hip score varied
from 18.7 to 24.6 points and, for Oxford knee score, from 13.1 to 18.8. Estimated 6-month
complications ranged from 2.9% to 5.8% for both THR and TKR.
CONCLUSIONS ANDRELEVANCE In this study, models indicated that higher surgical volume by
surgeon and by hospital as well as private hospitals were associated with better patient outcomes,
which could be explained by the changing case mix of public hospitals treating an increasing number
of more complex patients. A higher proportion of less experienced physicians was associated with
poorer outcomes. This variation was observed geographically.
JAMA Network Open. 2019;2(10):e1914325. doi:10.1001/jamanetworkopen.2019.14325
Introduction
Commissioners of health care, who are responsible for health services, need to be concerned about
the quality of health care that they commission, with a focus on quality improvement and reducing
unwarranted variations in quality and outcome.1 In the United Kingdom, the National Health Service
(NHS) Act 2006, as amended by the Health and Social Care Act 2012, places duties on the NHS
Commissioning Board and local clinical commissioning groups (CCGs) to work to reduce variations in
access to and outcomes from health care services for patients. These commissioners are also
required to assess and report on howwell they have fulfilled this duty.2
There are well-known geographical variations in the provision of common surgical procedures,
including total hip replacement (THR) and total or unicompartmental knee replacement (TKR),3 as
publicized through the NHS Atlas of Variation.1 For example, adjusted rates of provision per 1000
individuals in need of hip replacement ranged between a rate ratio of 12.2 and 144.0 across English
health districts.4 A 2014 study5 found evidence of significant unexplained variation between
hospitals in health outcomes and resource use following THR and TKR, but little is known about the
factors associated with such variation. We hypothesized that outcomes of surgery will vary across
different hospitals and areas of the country,5 that these variationsmay be associatedwith differences
in case mix, eg, more complex cases and patients with poorer health, and that this phenomenon
must be accounted for. However, differences in patient outcomes could also be associated with how
hospitals organize their services,4 eg, bed availability, numbers of operating theaters and specialist
surgeons, the use of new surgical techniques, such as minimally invasive surgery,6 and centralizing
care into specialist high-volume hospitals.7 Knowledge of these factors would help to change theway
services are organized, improve the quality of health care, and reduce geographical variation in
patient outcomes across health areas.
The specific gaps in knowledge that this article aims to address are as follows: (1) describe
geographical variation in patient outcomes for THR and TKR across different commissioning health
areas of England and (2) explore whether patient case mix, surgical, and/or hospital organizational
factors are associated with such variation.
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Methods
StudyDesign andData Source
We performed a retrospective cohort study using data obtained from the National Joint Registry
(NJR), which contains data on 2million THR and TKR replacement operations. Before personal data
and sensitive personal data are recorded, express written patient consent is provided. With support
under Section 251 of the NHS Act 2006, the ethics and confidentiality committee allows the NJR to
collect patient data where consent is indicated as not recorded. The ethical approval granted to NJR
also applied to this study. Primary operationswere linkedwith Hospital Episode Statistics (HES) data,
which contain records of all inpatient episodes undertaken in NHS trusts in England (125million per
year). In turn, primary THR and TKR were linked to Patient Reported Outcome Measures. Patients
funded by the NHS in England are asked to complete questionnaires to evaluate their perception of
improvement in health. Hospital organizational factors (ie, workforce, bed availability, and operating
theaters) were retrieved and linked to HES from the Hospital and Community Health Service
Workforce Statistics, the Quarterly Bed Availability and Occupancy, and the Supporting Facilities data
sets. Two cohorts who underwent primary THR and TKR operationswere retrieved for January 2014
throughDecember 2016, in England.We followed the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) reporting guideline.
MainOutcomeMeasures
We evaluated hospital length of stay (LOS) for patients undergoing primary THR and TKR. Length of
stay was calculated as the number of days between the hospital admission date and the hospital
discharge date. For the same set of patients used to estimate LOS, we estimated the inpatient cost
associated with the index episode, using NHS reference costs from 2015 to 2016.8We estimated the
mean cost per bed-day based on health care resource group, which refers to standard groupings of
clinically similar treatments that use common levels of health care resources, for each patient and
their LOS (eAppendix 1 in the Supplement).
Additionally, we assessed absolute change in Oxford hip and knee scores (OHS and OKS,
respectively). Patients completed a questionnaire about their pain and function before surgery and
6months after the surgery tomeasure early functional recovery.9 A total score is calculated from0 to
48, where 0 is the worst possible score (most severe symptoms) and 48 is the best (fewest
symptoms). We calculated the difference between the total scores 6months after the operation and
at baseline to obtain a measure of change associated with the surgery. A higher positive value for
OHS or OKS change represented greater improvement in pain and function. We defined
postoperative complications as 1 or more events that occurred up to 6months after the primary
replacement operation that would likely be related to the surgery (eAppendix 2 and eAppendix 3 in
the Supplement).
Potential Factors
We classified potential factors as patient, surgical, or hospital organizational factors (eTable 1 in the
Supplement). Patient factors included calendar year of THR or TKR; age; sex; body mass index,
calculated as weight in kilograms divided by height in meters squared10; American Society of
Anesthesiologists (ASA) grade11; area-level socioeconomic deprivation using the Index of Multiple
Deprivation, based on patient residential post code; rural vs urban indicator; primary indication;
Charlson Comorbidity Index (CCI) score; baseline OHS or OKS score; and the baseline European
Quality of Life-Five Domain (EQ-5D-3L) score. Surgical factors included lead surgeon experience,
surgical volume per lead surgeon and year, surgical volume per unit and year, minimally invasive
surgery (yes or no), thromboprophylaxis, mechanical prophylaxis, anesthetic type, and type of
approach. Hip bone grafts were classified as femoral bone graft or cup bone graft. Knee bone grafts
were classified as femoral bone graft or tibial bone graft. Hip implant fixation categories included cup
fixation and stem fixation, except resurfacing. Knee implant fixation categories included femoral
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fixation and tibial fixation.We also included the type of hip implant by bearing surface and by femoral
head size as well as the type of knee implant. Hospital organizational factors included unit type, full-
time equivalent (FTE; ie, proportion of full-time contracted hours) of specialty groups on trauma and
orthopedic surgery, FTE consultants, FTEmidgrade physicians, FTE early-career physicians, total
beds available overnight, total beds available overnight for trauma and orthopedic surgery, total beds
available overnight for rehabilitation, number of operating theaters, and number of dedicated
day-case operating theaters.
Exclusion Criteria
We included only patients receiving elective surgery (eFigure 1 in the Supplement). We excluded
patients without information about the census lower level super output area used to group patients
in geographical areas, which is necessary to conduct themultilevel modeling. Patients withmissing
data for LOS were also excluded. We excluded patients without information on baseline or 6-month
OHS or OKS scores for the analysis of change.
Missing Data
We used the Pearson χ2 statistic to evaluate missingness for OHS and OKS across categories of
confounders listed earlier. We compared the distribution of patients with and without data for OHS
andOKS by categories of those confounders. We generated a single imputed data set using a chained
equation.
Patient and Public Involvement
Among the priorities identified through the work of the James Lind Alliance Priority Setting
Partnership for Hip/Knee Replacement was the need to involve patients in identifying the outcomes
thatmattermost to them.12We used the University of Bristol Musculoskeletal Research Unit patient
involvement group, the Patient Experience Partnership in Research.13 This group comprises 12
patients with musculoskeletal conditions. The outcomesmost important to the group were pain and
function. Complications were considered important, particularly infection. The group agreed that
LOS was an important outcome but very dependent on the level of support at home. Revision,
reoperation, andmortality were ranked low by the group.
Statistical Analysis
The hierarchical structure of the data consisted of patients (level 1), nested in lower level super
output area (level 2) and in CCGs (level 3). Multilevel regressionmodels were used to describe the
association of patient, surgical, and hospital organization factors on patient outcomes of surgery.
This controlled for evidence of clustering in the data by allowing outcomes to vary across lower level
super output area and CCG. Failure to control for evidence of clustering can lead to estimates of
standard errors that are spuriously precise and be a potential source of bias. Analyses were
conducted separately for THR and TKR. We excluded nonsignificant terms using a backward
approach tomaximize statistical power, producingmodels with meaningful selected variables. The
overall outcomewas estimated for each CCG.We fitted the followingmodels: (1) null model of actual
observed outcomes, (2) model adjusted for patient case-mix variables, (3) model further adjusted
for surgical variables, and (4) model further adjusted for hospital organizational variables. We
produced ecological correlations of hospital factors at the health area–level with estimated
outcomes, using Pearson correlation tests. Variation in outcomes was presented using maps of the
2017 CCG areas.
Analyses were conducted using Stata version 15.1 (StataCorp), MLwiN version 3.00 (Centre for
Multilevel Modeling), and R version 3.5.0 (R Project for Statistical Computing). Statistical significance
was set at P = .05, and all tests were 2-tailed.
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Results
Between 2014 and 2016, there were 173 107 primary THRs and 210 275 primary TKRs (eFigure 1 in the
Supplement). A total of 223 296 surgical procedures (58.3%) were performed on women. Patients
undergoing THR had a mean (SD) age of 69.3 (10.7) and a mean (SD) body mass index of 28.9 (5.2);
patients undergoing TKR had a mean (SD) age of 69.7 (9.4) and mean (SD) body mass index of 31.1
(5.5) (Table 1). The American Society of Anesthesiologists grade of patients wasmild (ie, 2) or fit (ie, 1)
for patients in 317 452 surgical procedures (82.8%). Additional patient, surgical, and hospital
organization factors are summarized for THR and TKR in Table 1 and Table 2.
Outcomes
LOS andBed-Day Costs
Longer LOS was associated with patients aged 80 years or older (80-84 years, THR: regression
coefficient, 0.39; 95% CI, 0.38 to 0.41; P < .001; TKR: regression coefficient, 0.32; 95% CI, 0.30 to
0.34; P < .001;85 years, THR: regression coefficient, 0.59; 95% CI, 0.57 to 0.61; P < .001; TKR:
regression coefficient, 0.49; 95% CI, 0.47 to 0.51; P < .001), those with an ASA grade of 3 or higher
(grade 3, THR: regression coefficient, 0.17; 95% CI, 0.17 to 0.18; P < .001; TKR: regression coefficient,
0.15; 95% CI, 0.15 to 0.16; P < .001; grade 4-5, THR: regression coefficient, 0.36; 95% CI, 0.33 to
0.39; P < .001; TKR: regression coefficient, 0.32; 95% CI, 0.29 to 0.35; P < .001), and those with a
CCI score of 2 or higher (2, THR: regression coefficient, 0.16; 95% CI, 0.15 to 0.17; P < .001; TKR:
regression coefficient, 0.16; 95% CI, 0.15 to 0.16; P < .001;3, THR: regression coefficient, 0.30;
95% CI, 0.29 to 0.32; P < .001; TKR: regression coefficient, 0.28; 95% CI, 0.27 to 0.29; P < .001).
Shorter LOS was associated with private hospitals (THR: regression coefficient, −0.22; 95% CI, −0.23
to −0.21; P < .001; TKR: regression coefficient, −0.26; 95% CI, −0.27 to −0.26; P < .001) or private
treatment centers (THR: regression coefficient, −0.40; 95% CI, −0.41 to −0.38; P < .001; TKR:
regression coefficient, −0.44; 95% CI, −0.45 to −0.42; P < .001), high-volume hospitals (200 vs
500 surgical procedures per year, THR: regression coefficient, 0.14; 95% CI, 0.13 to 0.15; P < .001;
TKR: regression coefficient, 0.10; 95% CI, 0.09 to 0.11; P < .001), operations performed by lead
surgeons (less-experienced surgeons, THR: regression coefficient, 0.02; 95% CI, 0.01 to 0.03;
P < .001; TKR: regression coefficient, 0.01; 95%CI, 0.01 to 0.02; P < .001), and among patients in the
highest quintile of EQ-5D-3L scores (fourth quintile vs highest quintile, THR: regression coefficient,
−0.22; 95% CI, −0.23 to −0.21; P < .001; highest quintile vs lowest quintile, TKR: regression
coefficient, −0.18; 95% CI, −0.19 to −0.18; P < .001) (eTable 2 and eTable 3 in the Supplement).
Hospitals with 100 or more beds available overnight for trauma and orthopedics were associated
with longer LOS for THR than hospitals with fewer than 35 beds (regression coefficient, 0.16; 95% CI,
0.14 to 0.17; P < .001) (eTable 2 in the Supplement). Patients undergoing TKRwere associated with
longer LOS than those undergoing UKR (regression coefficient, 0.28; 95% CI, 0.27 to 0.29; P < .001)
(eTable 3 in the Supplement). The percentage of public and private hospitals was ecologically
correlated at CCG level with longer and shorter stays, respectively (public hospital, THR: ρ, 0.41;
public hospital, TKR: ρ, 0.44; private hospital, THR: ρ, −0.37; private hospital, THR: ρ, −0.38)
(Figure 1; eTable 4 in the Supplement).
Observedmean bed-day costs by CCG ranged between £4322 ($5328) and £8566 ($10 559) for
THR and £4564 ($5626) to £8901 ($10 972) for TKR. Higher bed-day costs were found for older
patients (85 years, THR: regression coefficient, 0.42; 95% CI, 0.42 to 0.42; P < .001; TKR:
regression coefficient, 0.35; 95% CI, 0.35 to 0.35; P < .001), those with an ASA grade of 3 or higher
(grade 3, THR: regression coefficient, 0.09; 95% CI, 0.09 to 0.09; P < .001; TKR: regression
coefficient, 0.09; 95% CI, 0.09 to 0.09; P < .001; grade 4-5, THR: regression coefficient, 0.18; 95%
CI, 0.18 to 0.18; P < .001; TKR: regression coefficient, 0.17; 95% CI, 0.17 to 0.17; P < .001), and those
with a CCI score of 3 or higher (THR: regression coefficient, 0.08; 95% CI, 0.08 to 0.08; P < .001;
TKR: regression coefficient, 0.09; 95% CI, 0.09 to 0.09; P < .001) (eTable 5 and eTable 6 in the
Supplement). Lower bed-day costs were associated with private hospitals (THR: regression
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Table 1. Distribution of Patient and Surgical Factors AssociatedWith Patient Outcomes of Surgery
Factor
No. (%)
THR (n = 173 107) TKR or UKR (n = 210 725)
Patient Factors
Calendar year
2014 57 156 (33.0) 69 001 (32.7)
2015 57 535 (33.2) 69 999 (33.2)
2016 58 416 (33.8) 71 725 (34.0)
Age, y
<50 7907 (4.6) 4180 (2.0)
50-59 22 887 (13.2) 26 789 (12.7)
60-69 51 097 (29.5) 68 970 (32.7)
70-79 61 994 (35.8) 79 241 (37.6)
80-84 19 426 (11.2) 21 753 (10.3)
≥85 9796 (5.7) 9792 (4.7)
Women 103 860 (60.0) 119 436 (56.7)
BMI, mean (SD) 28.9 (5.2) 31.1 (5.5)
Preoperative ASA physical
function score
1, Fit and healthy 22 195 (12.8) 18 909 (9.0)
2, Mild disease, not incapacitating 121 255 (70.1) 155 093 (73.6)
3, Incapacitating systemic disease 28 945 (16.7) 36 171 (17.2)
4-5, Life-threatening disease
or expected to die within 24 h
712 (0.4) 552 (0.3)
IMD quintile
Lowest quintile, least deprived 42 058 (24.3) 46 435 (22.0)
Second quintile 43 001 (24.8) 49 019 (23.3)
Third quintile 31 200 (18.0) 40 216 (19.1)
Fourth quintile 29 289 (16.9) 38 292 (18.2)
Highest quintile, most deprived 27 559 (15.9) 36 763 (17.5)
Rural/urban indicator
Urban 123 862 (71.6) 157 758 (74.9)
Town and fringe 22 223 (12.8) 25 083 (11.9)
Village or isolated 27 022 (15.6) 27 884 (13.2)
Primary indication
Osteoarthritis 167 686 (96.9) 208 333 (98.9)
Osteoarthritis and othera 5421 (3.1) 2392 (1.1)
Charlson Comorbidity Index score
0 122 047 (70.5) 140 711 (66.8)
1 32 926 (19.0) 46 984 (22.3)
2 11 870 (6.9) 15 341 (7.3)
≥3 6264 (3.6) 7689 (3.7)
Baseline OHS or OKS, median (IQR) 17 (11-23) 18 (12-23)
EQ-5D-3L quintile
Lowest quintile, lowest quality of life 21 265 (12.3) 40 798 (19.4)
Second quintile 47 303 (27.3) 29 601 (14.1)
Third quintile 35 237 (20.4) 54 583 (25.9)
Fourth quintile 32 083 (18.5) 20 352 (9.7)
Highest quintile, highest quality of life 37 219 (21.5) 65 391 (31.0)
Surgical Factors
Lead surgeon experience
Consultant 143 417 (82.9) 172 183 (81.7)
Otherb 29 690 (17.2) 38 542 (18.3)
(continued)
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Table 1. Distribution of Patient and Surgical Factors AssociatedWith Patient Outcomes of Surgery (continued)
Factor
No. (%)
THR (n = 173 107) TKR or UKR (n = 210 725)
Surgical procedures per lead surgeon, No./y
≤10 3013 (1.4) 3109 (1.8)
11-50 45 279 (21.5) 37 816 (21.9)
51-75 41 610 (19.8) 30 651 (17.7)
76-100 38 898 (18.5) 30 979 (17.9)
101-150 45 056 (21.4) 36 610 (21.2)
>150 36 869 (17.5) 33 942 (19.6)
Surgical procedures per unit, No./y
≤200 45 319 (26.2) 31 321 (14.9)
200-299 47 040 (27.2) 51 335 (24.4)
300-399 37 984 (21.9) 50 346 (23.9)
400-499 10 159 (5.9) 32 782 (15.6)
≥500 32 605 (18.8) 44 941 (21.3)
Minimally invasive surgery 7076 (4.1) 9332 (4.4)
Thromboprophylaxis
None 1598 (0.9) 2049 (1.0)
Aspirin only 5219 (3.0) 7111 (3.4)
LMWH, with or without other 109 443 (63.2) 152 836 (72.5)
Other, no LMWH 56 847 (32.8) 48 729 (23.1)
Mechanical prophylaxis 167 638 (96.8) 204 642 (97.1)
Anesthetic type
General 56 951 (32.9) 62 447 (29.6)
Regional, epidural 5230 (3.0) 6841 (3.3)
Regional, nerve block 8824 (5.1) 21 619 (10.3)
Regional, spinal, intrathecal 131 627 (76.0) 157 123 (74.6)
Approach
Anterior, antero-lateral, hardinge, lateral,
trochanteric osteotomy, or other
55 100 (31.8) NA
Posterior 118 007 (68.2) NA
Lateral parapatellar NA 1907 (0.9)
Medial parapatellar NA 197 718 (93.8)
Midvastus NA 5942 (2.8)
Subvastus NA 2302 (1.1)
Other approaches in knee surgery NA 2856 (1.4)
Bone grafts
Femoralc 921 (0.5) 2225 (1.1)
Cup 5669 (3.3) NA
Tibia NA 705 (0.3)
Primary cup fixation
Cementless 110 862 (64.4) NA
Cemented 61 415 (35.7) NA
Type of primary stem fixation
Cementless 72 509 (42.4) NA
Cemented 98 607 (57.6) NA
Primary femoral fixation
Cementless NA 9461 (4.5)
Cemented NA 200 741 (95.5)
Tibial fixation
Cementless NA 8855 (4.2)
Cemented NA 201 226 (95.8)
(continued)
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coefficient, −0.15; 95% CI, −0.15 to −0.14; P < .001; TKR: regression coefficient, −0.19; 95% CI, −0.19
to −0.19; P < .001) or private treatment centers (THR: regression coefficient, −0.29; 95% CI, −0.29
to −0.29; P < .001; TKR: regression coefficient, −0.33; 95% CI, −0.33 to −0.33; P < .001), high-
volume lead surgeons and hospitals (lead surgeon with10 vs >150 surgical procedures per year,
THR: regression coefficient, 0.02; 95% CI, 0.02 to 0.02; P < .001; TKR: regression coefficient, 0.02;
95% CI, 0.02 to 0.02; P < .001; hospitals with200 vs500 surgical procedures per year, THR:
regression coefficient, 0.11; 95% CI, 0.11 to 0.11; P < .001; TKR: regression coefficient, 0.08; 95% CI,
0.08 to 0.08; P < .001), and among patients in the highest quintile of EQ-5D-3L scores (fourth
quintile vs highest quintile, THR: regression coefficient, −0.15; 95% CI, −0.15 to −0.15; P < .001;
highest quntile vs lowest quintile, TKR: regression coefficient, −0.13; 95% CI, −0.13 to −0.13; P < .001)
(eTable 5 and eTable 6 in the Supplement).
OHS andOKS Change
Greater absolute change in OHS and OKS scores at 6months was associated with private hospitals
(THR: regression coefficient, 0.75; 95% CI, 0.61 to 0.90; P < .001; TKR: regression coefficient, 0.73;
95% CI, 0.57 to 0.88; P < .001), high-volume lead surgeons (lead surgeon with10 vs >150 surgical
procedures per year, THR: regression coefficient, −1.03; 95% CI, −1.47 to −0.58; P < .001; TKR:
regression coefficient, −0.54; 95% CI, −1.01 to −0.06; P = .03), better preoperative EQ-5D-3L scores
(fourth quintile vs highest quintile, THR: regression coefficient, 3.86; 95%CI, 3.56 to 4.16; P < .001;
highest quintile vs lowest quintile, TKR: regression coefficient, 3.77; 95% CI, 3.56 to 3.98; P < .001),
lower CCI scores (3, THR: regression coefficient, −1.03; 95% CI, −1.36 to −0.71; P < .001; TKR:
regression coefficient, −1.22; 95%CI, −1.53 to −0.91; P < .001), and better ASA grade (grade 4-5, THR:
regression coefficient, −2.37; 95% CI, −3.41 to −1.34; P < .001; TKR: regression coefficient, −2.94;
95% CI, −4.19 to −1.69; P < .001) (eTable 7 and eTable 8 in the Supplement). Greater change in OHS
was associated with bigger femoral head size (44 mm vs28 mm: regression coefficient, 2.07;
95% CI, 0.28 to 3.86; P = .02) and less deprived areas (lowest quintile vs highest quintile: regression
coefficient, 1.50; 95% CI, 1.30 to 1.70; P < .001). Patients aged 60 years or older were associated
with greater change in OKS score (eg, age 70-79: regression coefficient, 2.86; 95% CI, 2.33 to 3.39;
P < .001).
Complication at 6Months
A higher probability of developing complications in the 6months after surgery was associated with
older age (85 years, THR: regression coefficient, 1.10; 95% CI, 0.91 to 1.28; P < .001; TKR:
Table 1. Distribution of Patient and Surgical Factors AssociatedWith Patient Outcomes of Surgery (continued)
Factor
No. (%)
THR (n = 173 107) TKR or UKR (n = 210 725)
Bearing surface
MoM 991 (0.6) NA
MoP 106 548 (62.1) NA
CoC 20 821 (12.1) NA
CoP 43 138 (25.2) NA
CoM, MoC, or unknown 23 (0.1) NA
Femoral head size, mm
≤28 55 652 (32.4) NA
32 75 536 (44.0) NA
36-42 39 556 (23.0) NA
≥44 1141 (0.7) NA
Type of knee implant
Total knee replacement NA 194 464 (92.3)
Unicompartmental knee replacement NA 16 261 (7.7)
Abbreviations: ASA, American Society of
Anesthesiologists; BMI, bodymass index (calculated as
weight in kilograms divided by height in meters
squared); CoC, ceramic-on-ceramic; CoM, ceramic-on-
metal; CoP, ceramic-on-polyethylene; EQ-5D-3L,
European Quality of Life-5 Domain; IMD, Index of
Multiple Deprivation; IQR, interquartile range; LMWH,
low-molecular-weight heparin;MoM,metal-on-metal;
MoP,metal-on-polyethylene;MoC,metal-on-ceramic;
NA, not applicable; OHS, Oxford hip score; OKS,
Oxford knee score; THR, total hip replacement; TKR,
total knee replacement; UKR, unicompartmental knee
replacement.
a List of indications appears in eTable 1 in the
Supplement.
b Other types of physicians appear in eTable 1 in the
Supplement.
c Implanted in head of the femur for hips and distal
part of the femur for knees.
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Table 2. Distribution of Hospital Factors AssociatedWith Patient Outcomes of Surgery
Factor
No. (%)
THR (n = 173 107) TKR or UKR (n = 210 725)
Unit type
Public hospital 123 481 (71.3) 148 758 (70.6)
Private hospital 40 842 (23.6) 50 739 (24.1)
Private treatment center 8784 (5.1) 11 228 (5.3)
FTE specialty groups on trauma
and orthopedic surgery, No.
0-24 20 558 (11.9) 63 415 (30.1)
25-29 17 541 (10.1) 29 416 (14.0)
30-39 32 725 (18.9) 47 334 (22.5)
40-49 32 528 (18.8) 28 572 (13.6)
>50 69 755 (40.3) 41 988 (19.9)
FTE consultants, No.
0-24 40 108 (23.2) 92 154 (43.7)
25-29 15 788 (9.1) 21 437 (10.2)
30-39 32 530 (18.8) 33 396 (15.9)
40-49 23 966 (13.8) 25 209 (12.0)
>50 60 715 (35.1) 38 529 (18.3)
FTE midgrade physicians, No.
0-24 97 397 (56.3) 151 270 (71.8)
25-29 18 900 (10.9) 17 590 (8.4)
30-39 21 667 (12.5) 19 425 (9.2)
40-49 14 362 (8.3) 9306 (4.4)
>50 20 781 (12.0) 13 134 (6.2)
FTE early-career physicians, No.
0-24 168 646 (97.4) 208 405 (98.9)
25-29 3757 (2.2) 2055 (1.0)
30-39 704 (0.4) 265 (0.1)
40-49 0 0
>50 0 0
Total beds available overnight, No.
0-349 15 186 (8.8) 41 447 (19.7)
350-499 18 469 (10.7) 40 887 (19.4)
500-699 34 541 (20.0) 51 403 (24.4)
700-999 51 891 (30.0) 41 415 (19.7)
≥1000 53 020 (30.6) 35 573 (16.9)
Beds available overnight for trauma
and orthopedic surgery, No.
0-34 15 873 (9.2) 59 732 (28.4)
35-49 26 118 (15.1) 46 946 (22.3)
50-69 47 209 (27.3) 53 577 (25.4)
70-99 52 178 (30.1) 32 574 (15.5)
≥100 31 729 (18.3) 17 896 (8.5)
Beds available overnight for rehabilitation, No.
0 74 465 (57.8) 59 793 (54.5)
>0-10 9605 (7.5) 8695 (7.9)
11-20 16 923 (13.1) 15 651 (14.3)
≥20 27 754 (21.6) 25 655 (23.4)
Operating theaters, No.
<10 11 278 (6.5) 53 927 (25.6)
10-14 26 830 (15.5) 45 205 (21.5)
15-19 38 320 (22.1) 42 661 (20.2)
20-24 27 414 (15.8) 22 226 (10.6)
≥25 69 265 (40.0) 46 706 (22.2)
(continued)
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regression coefficient, 0.55; 95% CI, 0.37 to 0.73; P < .001), a CCI score of 3 or higher (THR:
regression coefficient, 0.74; 95% CI, 0.64 to 0.83; P < .001; TKR: regression coefficient, 0.68; 95%
CI, 0.58 to 0.77; P < .001), an ASA grade of 4 or 5 (THR: regression coefficient, 0.82; 95% CI, 0.59 to
1.04; P < .001; TKR: regression coefficient, 0.88; 95% CI, 0.62 to 1.14; P < .001), lower-volume
hospitals (hospitals with200 vs500 surgical procedures per year, THR: regression coefficient,
0.12; 95% CI, 0.04 to 0.21; P < .001; TKR: regression coefficient, 0.09; 95% CI, 0.01 to 0.18; P = .03),
and public hospitals (private hospitals, THR: regression coefficient, −0.08; 95% CI, −0.15 to −0.01;
P = .03; TKR: regression coefficient, −0.10; 95% CI, −0.16 to −0.04; P < .001) (eTable 9 and eTable 10
in the Supplement). Hospitals conducting more surgical procedures per year correlated ecologically
at the CCG level with a lower percentage of complications (THR: ρ, −0.38; TKR: ρ, −0.26), while
hospitals with higher proportion of midgrade or early-career physicians correlated with higher
percentage of complications (midgrade physicians, THR: ρ, 0.20; TKR: ρ, 0.19; early-career
physicians, THR: ρ, 0.21; TKR: ρ, 0.19) (eTable 4 in the Supplement). For THR, thromboprophylaxis
based on aspirin only was associated with complications at 6 months (regression coefficient, 0.19;
95% CI, 0.04 to 0.34; P = .01) (eTable 9 in the Supplement). Fewer complications were associated
with minimally invasive hip replacement surgery (regression coefficient, −0.27; 95% CI, −0.43 to
−0.12; P < .001). For TKR, private treatment centers (regression coefficient, −0.30; 95% CI, −0.42 to
−0.17; P < .001) and unicompartmental implants (regression coefficient, 0.41; 95%CI, 0.30 to 0.52;
P < .001) were associated with a lower percentage of complications 6months after surgery.
Table 2. Distribution of Hospital Factors AssociatedWith Patient Outcomes of Surgery (continued)
Factor
No. (%)
THR (n = 173 107) TKR or UKR (n = 210 725)
Dedicated day-case operating theaters, No.
0 24 951 (14.4) 39 251 (18.6)
1-2 32 531 (18.8) 51 685 (24.5)
3-4 37 891 (21.9) 47 745 (22.7)
5-6 42 126 (24.3) 27 857 (13.2)
≥7 35 608 (20.6) 44 187 (21.0)
Abbreviation: FTE, full-time equivalent.
Figure 1. Correlation Between Bed-Day Costs and Percentage of Knee Replacements
in Public and Private Hospitals by Health Area in England, 2014-2016
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Variation in Outcomes
LOS andBed-Day Costs
Observed (ie, unadjusted) mean LOS by CCG ranged from 2.5 to 6.2 days for THR and from 2.7 to 6.6
days for TKR. Fully adjustedmodels show that variability across CCGs remained high; for THR, 73 of
207 CCGs (35.3%) had shortermean LOS, and 86 CCGs (41.5%) had longermean LOS than the overall
mean (Figure 2A). We also observed variability between CCGs for patients undergoing TKR, with 87
CCGs (42.0%) with shorter mean LOS and 75 CCGs (36.2%) with longer mean LOS (eFigure 2 in the
Supplement). The 5 CCGs with shortest mean LOS and the 5 CCGs with the longest mean LOS appear
in eTable 11 in the Supplement. Maps of England with CCG boundaries show the London region had
a longer mean LOS for both THR and TKR, while North England and the East had shorter mean LOS
estimates for THR and TKR (Figure 3A and Figure 4A).14
Mean (SD) bed-day costs for THR ranged between £4727 (£1026) ($5827 [$1265]) in NHS
Scarborough and Ryedale CCG (within the Yorkshire and the Humber region) and £8800 (£1572)
($10 848 [$1938]) in NHS Hillingdon CCG (within the London region) (eTable 11 in the Supplement).
Mean (SD) bed-day costs for TKR ranged between £4758 (£1096) ($5865 [$1351]) in NHS
Scarborough and Ryedale CCG and £8692 (£1507) ($10 714 [$1858]) in NHS Central London CCG
(eTable 11 in the Supplement). Those CCGs were consistently ranked high or low during the study
period (2014-2016) for LOS and costs (eFigure 3 and eFigure 4 in the Supplement).
OHS andOKS Change
Observed (ie, unadjusted) mean OHS change by CCG ranged from 17.5 to 24.9 points; mean OKS
change by CCG ranged from 11.2 to 19.1 points. Caterpillar plots exploring the variability of OHS
change in fully adjusted models demonstrated less variability between CCGs than for OKS change,
with 63 CCGs (30.4%) having lower OHS change and 45 (21.7%) having higher OHS change
(Figure 2C). Variation between CCGs was greater for OKS change with 78 CCGs (37.7%) having less
Figure 2. Caterpillar Plots of Patient Outcomes for Primary Hip Replacement by Health Area in England, 2014-2016
Variability of length of stay, ranked by CCGA Variability of bed-day costs, ranked by CCGB
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OKS change and 55 (26.6%) having greater OKS change (eFigure 2 in the Supplement). Mean (SD)
OHS improvement ranged from 24.6 (5.3) points and 18.7 (6.2) points (Figure 3C; eTable 11 in the
Supplement). Mean (SD) OKS improvement ranged from 18.8 (4.2) points to 13.1 (4.3) points
(Figure 4C; eTable 11 in the Supplement). For OHS change, the same CCGs were consistently outliers
during the study period, but there was variability in which CCGs were outliers for the OKS change
(eFigure 3 and eFigure 4 in the Supplement).
Complication at 6Months
Observed (ie, unadjusted) complications at 6months by CCG ranged from 2.0% to 8.6% for THR and
from 1.5% to 8.4% for TKR. Fully adjusted models for complications at 6 months showed 66 CCGs
(31.9%) had higher complications for patients undergoing THR (Figure 2D). There was more
Figure 3. Maps of Patient Outcomes for Primary Hip Replacement Across 207 Health Areas in England, 2014-2016
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variability for TKR, where 81 CCGs (39.1%) had higher rates of complications (eFigure 2 in the
Supplement). Complications at 6months ranged between 2.9% and 5.8% (eTable 11 in the
Supplement) for patients with THR and TKR.Maps of CCGs show that the London region had a higher
percentage of complications (Figure 3D and Figure 4D). Variability over the study period for
complications at 6months was consistent for the 5 CCGs with lower mean percentage of
complications but changed for the 5 CCGs with a higher mean percentage of complications at 6
months (eFigure 3 and eFigure 4 in the Supplement).
Discussion
We have previously shown15 that patient outcomes have been improving substantially during the
past decade, with shorter mean LOS, greater reductions in pain, greater improvements in functional
Figure4.MapsofPatientOutcomes forPrimaryKneeReplacementAcross207HealthAreas inEngland, 2014-2016
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outcome, and fewer surgical complications. However, despite these improvements, using themost
recent years of NJR data (ie, 2014-2016), we found that there is still substantial variation in patient
outcomes for THR and TKR across CCG areas that remained after adjusting for patient case mix and
surgical factors. Hospital organizational factors had some influence on explaining this variation, as
is demonstrated in the ecological correlations at CCG level. Variation in outcomes between CCGs was
greater for TKR than for THR. Length of stay had high variation between CCGs (eg, for TKR, 87 CCGs
[42.0%] had shorter LOS, and 75 CCGs [36.2%] had longer). There was less variation between CCGs
for OHS and OKS change outcomes (eg, 78 CCGs [37.7%] with smaller OKS change and 55 CCGs
[26.6%] with larger), while there was relatively little CCG variation for complications 6months after
surgery. The substantial variation within each CCG for the OHS and OKS change outcomes
was notable.
There are a large number of studies within the literature that have identified factors associated
with patient outcomes for THR and TKR. A large observational study16 involving 10 961 primary THR
and 10 260 primary TKR in the United Kingdom found that older age at surgery was associated with
longer LOS (patients aged 55 years, THR: regression coefficient, 6.2; 95%CI 5.9-6.4; TKR: regression
coefficient, 5.7; 95% CI, 5.5-5.9; patients aged 85 years, THR: regression coefficient, 10.6; 95% CI,
10.1-11.0; TKR: regression coefficient, 9.1; 95% CI, 8.7-9.5). Longer stays were also associated with
lower socioeconomic status, and shorter stays were associated with male sex.16 However, LOS
literature is mostly in the context of enhanced recovery interventions,17 where our previous work
showed that older age and comorbidity were associated with longer LOS.15 Regarding patient
case-mix variables, it has been shown that lower baseline levels of pain and functional disease
severity,3,18,19 age,20 sex,18 obesity,18,20 comorbidities,18,19 and socioceconomic deprivation21,22 are
all associated with patient-reported outcomes of postoperative pain and function. Less is known
about factors associated with rarer outcomes, such as complications of surgery, but we have
previously shown23 that such complications are rare and that obesity was associated with small but
clinically insignificant effects. Much of this work on factors associated with the outcomes of hip and
knee replacement surgery has been formally synthesized within large systematic reviews.24
We have previously demonstrated25 evidence of geographical variation and inequity in access
to THR and TKR surgery for patients who underwent operations in 2002 (between 12 and 14 years
before the patients in our study had their operations). However, among patients who navigate the
care pathway and obtain access to joint replacement surgery, there has been little research exploring
geographical variations in the outcomes of such common surgical procedures, and there is a strong
need to identifymodifiable process factors that are associatedwith variations in outcome. A previous
study by Street et al5 used HES data to explore variation in Patient Reported OutcomeMeasures for
THR and TKR across hospitals in England. Using multilevel regression modeling, they looked at
whether patient factors (ie, age, sex, comorbidity, and socioeconomic deprivation) and hospital
factors (ie, volume and teaching hospital status) were associated with health outcomes (ie,
EQ-5D-3L, OHS, and OKS) and resource use (ie, LOS and hospital costs). The key findings were
significant unexplained variation among hospitals in both health outcomes and resource use. This is
consistent with the findings of our study; however, our research moves this forward by looking at
variation in other relevant outcomes (ie, bed-day costs and complications) and at a broader range of
surgical and hospital organizational factors that may be associated with geographical variation in
patient outcomes, adjusted for patient case mix. Our findings suggest that such factors do not fully
explain this variation. Hence, there are likely other unmeasured, historical organizational factors and
processes specific to individual local hospitals that may be associated with such variation.
Birkmeyer et al26 suggested in a narrative review that surgical variation results mainly from
differences in physician beliefs about the indications for surgery and the extent to which patient
preferences are incorporated into treatment decisions, whichmight indicate an underuse of the
procedure in some regions and/or an overuse in others.2 Previous research27 has shown that public
hospitals that had a private hospital close by experienced substantial reductions in presurgery length
of stay for hip and knee replacement, and the authors suggested that hospitals exposed to
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competition from new private entrants becamemore efficient. However, the negative consequence
was aworsening in the complexity and casemix of patients being treated in the public hospitals, with
this contributing to an increase in public hospitals’ postsurgery LOS. While policy makers may have
intended this differential in healthy and less healthy (ie, straightforward andmore complex) patients
between public and private hospitals, there have potentially been unintended consequences. The
ecological correlations at CCG level that we observed between the public and private hospitals in
bed-day costs and the other outcomes could be explained by greater hospital efficiencies in the
private setting but also by the changing case mix of public hospitals treating an increasing number of
more complex patients, patients with poorer health, more patients with obesity, and older patients
in those areas with competing private hospitals, which might explain regional variability.27,28 In
addition, health areas with hospitals and lead surgeons performing a higher volume of joint
replacement procedures per year could explain variation between regions. However, the proportion
of total variance explained by the health area level was low (eg, 0.5% and 1.2% for OHS and OKS
outcomes, respectively). Although we have shown that this phenomenon is unlikely to be associated
with population differences, as we have accounted for patient case-mix factors, there will still be
residual confounding and selection bias, particularly between patient selection at public and private
hospitals, that cannot be fully accounted for by adjustment in a regressionmodel and observational
study design.
Strengths and Limitations
Strengths of the study include use of the NJR data set, which is the largest arthroplasty data set in the
world, without restricting analysis to a certain group of patients or implant providers. This allowed
us to generalize the results to the English population. The NJR has near complete coverage of all
arthroplasties, particularly since 2011, when the Department of Health made NJR compliance
mandatory. Linkage to HES allowed us to examine a wide range of comorbidities and to link hospital
organizational factors; however, analysis was restricted to England and private operations were not
included in the HES data set. The large sample size allowed us to explore geographical variation in
rare outcomes of rare complications.
Themain limitations of the study are missing data, which were particularly prevalent for the
hospital organizational factors. To overcome this, we usedmultiple imputationmethods, but only
single imputation was possible given the complexity of themultilevel regressionmodels fitted. The
main limitation of observational studies like ours is the potential for residual confounding, particularly
for patient case-mix variables, owing to other measures of patient case mix not fully accounted for
in our models (eg, the type of work that patients are returning to, levels of depression, availability of
social support on discharge, and assumptions about weighting in the CCI) that may not reflect the
relative weight of different comorbidities’ association with THR and TKR outcomes. There may also
be differences in the way that surgery is performed in different units that were not captured by our
data. Historically, units and regions adopt surgical practices that may influence outcome, eg, every
physician in a unit uses a tourniquet or excises the fat pad in total knee replacement operations.
However, this is, to our knowledge, themost thorough attempt to adjust for a very wide range of
patient, surgical, and hospital factors, and given themagnitude of variation that remains, particularly
for LOS, there would have to be strong residual confounding that is not correlated with the
confounders already adjusted for to fully explain the remaining variability.
Conclusions
Ourmodels indicated that better outcomes for THR and TKRwere associated with higher surgical
volume by surgeon and hospital as well as private hospitals. A higher proportion of less experienced
physicians by hospital was associated with poorer outcomes. The ecological correlations observed
between the public and private hospitals could be explained by the changing case mix of public
hospitals treating an increasing number of more complex patients.
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